A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

May 3, 2027

Study Completion Date

May 3, 2027

Conditions

Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial SpondyloarthritisHidradenitis Suppurativa

Interventions

DRUG

Bimekizumab

Bimekizumab under the care of their treating physician.

Trial Locations (1)

RECRUITING

Up0122 202, Calgary

All Listed Sponsors

lead

UCB Biopharma SRL

INDUSTRY